Profile: Micardia Corporation focuses on implantable devices for dynamic repair of heart valves & interruption of progression to heart failure. We provide treatments for mitral regurgitation recurrence, tricuspid regurgitation recurrence, mitral valve prolapse, ischemic heart disease and congestive heart failure. Our treatments include tricuspid & mitral valve medication and tricuspid & mitral valve surgery. Our tricuspid & mitral valve treatment is used to protect the valve from further damage, lessening symptoms & repairing or replacing valves. Our surgical options include mitral or tricuspid valve repair or replacement. This method is used to repair the valves, with a minimally invasive heart valve surgical procedure. Our ischemic mitral valve regurgitation comprises of revascularization, ring annuloplasty, valve repair and replacement or left ventricular reconstruction by way of reshaping or resection. We also offer Micardia Dynaplasty® annuloplasty rings which may be adjusted intra-operatively or post-operatively, after they are surgically placed in either the mitral valve annulus or tricuspid valve annulus positions.